Press release
Stem Cell Mobilization Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Teva Pharmaceuticals, Gilead Sciences
"Stem Cell Mobilization Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Stem Cell Mobilization Market.
The Stem Cell Mobilization Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Stem Cell Mobilization Pipeline Report: https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Stem Cell Mobilization treatment therapies with a considerable amount of success over the years.
• Stem Cell Mobilization companies working in the treatment market are Magenta Therapeutics, BioLineRx, and others, are developing therapies for the Stem Cell Mobilization treatment
• Emerging Stem Cell Mobilization therapies in the different phases of clinical trials are- AVA4746, Balixafortide, Burixafor, MGTA 145, Motixafortide, and others are expected to have a significant impact on the Stem Cell Mobilization market in the coming years.
• In May 2025, Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotech focused on hematologic disease treatments, has announced the completion of patient enrollment in its ongoing Phase 2 clinical trial (NCT05561751). The study is evaluating the safety and efficacy of GPC-100 (burixafor) in combination with propranolol and G-CSF in patients with multiple myeloma undergoing autologous stem cell transplant (ASCT). This randomized, open-label, multicenter trial aims to determine whether GPC-100, a small molecule CXCR4 antagonist, can enhance the mobilization of CD34+ hematopoietic stem cells from the bone marrow into the bloodstream for efficient collection via leukapheresis for ASCT.
• In November 2024, BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial-stage biopharmaceutical company focused on transformative therapies in oncology and rare diseases, has announced that initial findings from its Phase 1 clinical trial of motixafortide-used alone and in combination with natalizumab-have been accepted for oral presentation at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition, scheduled for December 7-10, 2024, in San Diego, California. The trial, conducted in collaboration with Washington University School of Medicine in St. Louis, investigates novel strategies for mobilizing CD34+ hematopoietic stem cells in patients with sickle cell disease (SCD) undergoing gene therapy, aiming to enhance their treatment experience.
Stem Cell Mobilization Overview
Stem cell mobilization is a medical process designed to encourage stem cells, which are typically located in the bone marrow, to move from the bone marrow into the bloodstream. This process is often employed before stem cell transplantation, allowing for the collection of stem cells from the blood for therapeutic purposes.
Get a Free Sample PDF Report to know more about Stem Cell Mobilization Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Stem Cell Mobilization Molecule Type
Stem Cell Mobilization Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Stem Cell Mobilization Pipeline Therapeutics Assessment
• Stem Cell Mobilization Assessment by Product Type
• Stem Cell Mobilization By Stage and Product Type
• Stem Cell Mobilization Assessment by Route of Administration
• Stem Cell Mobilization By Stage and Route of Administration
• Stem Cell Mobilization Assessment by Molecule Type
• Stem Cell Mobilization by Stage and Molecule Type
DelveInsight's Stem Cell Mobilization Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Stem Cell Mobilization product details are provided in the report. Download the Stem Cell Mobilization pipeline report to learn more about the emerging Stem Cell Mobilization therapies at:
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Stem Cell Mobilization Therapeutics Market include:
Key companies developing therapies for Stem Cell Mobilization are - Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Teva Pharmaceuticals, Gilead Sciences, Merck & Co., Bristol Myers Squibb, and others.
Stem Cell Mobilization Pipeline Analysis:
The Stem Cell Mobilization pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Stem Cell Mobilization with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Stem Cell Mobilization Treatment.
• Stem Cell Mobilization key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Stem Cell Mobilization Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Stem Cell Mobilization market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Stem Cell Mobilization drugs and therapies-
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Stem Cell Mobilization Pipeline Market Drivers
• Increase in prevalence of Solid Tumors, novel pathways being explored in animal and early human studies are some of the important factors that are fueling the Stem Cell Mobilization Market.
Stem Cell Mobilization Pipeline Market Barriers
• However, high cost of therapy, challenges associated with the analysis of genetic factors responsible for the great variability in mobilization responses, poor Understanding of the mechanisms underlying the process of HSPC mobilization and other factors are creating obstacles in the Stem Cell Mobilization Market growth.
Scope of Stem Cell Mobilization Pipeline Drug Insight
• Coverage: Global
• Key Stem Cell Mobilization Companies: Magenta Therapeutics, BioLineRx, and others
• Key Stem Cell Mobilization Therapies: AVA4746, Balixafortide, Burixafor, MGTA 145, Motixafortide, and others
• Stem Cell Mobilization Therapeutic Assessment: Stem Cell Mobilization current marketed and Stem Cell Mobilization emerging therapies
• Stem Cell Mobilization Market Dynamics: Stem Cell Mobilization market drivers and Stem Cell Mobilization market barriers
Request for Sample PDF Report for Stem Cell Mobilization Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Stem Cell Mobilization Report Introduction
2. Stem Cell Mobilization Executive Summary
3. Stem Cell Mobilization Overview
4. Stem Cell Mobilization- Analytical Perspective In-depth Commercial Assessment
5. Stem Cell Mobilization Pipeline Therapeutics
6. Stem Cell Mobilization Late Stage Products (Phase II/III)
7. Stem Cell Mobilization Mid Stage Products (Phase II)
8. Stem Cell Mobilization Early Stage Products (Phase I)
9. Stem Cell Mobilization Preclinical Stage Products
10. Stem Cell Mobilization Therapeutics Assessment
11. Stem Cell Mobilization Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Stem Cell Mobilization Key Companies
14. Stem Cell Mobilization Key Products
15. Stem Cell Mobilization Unmet Needs
16 . Stem Cell Mobilization Market Drivers and Barriers
17. Stem Cell Mobilization Future Perspectives and Conclusion
18. Stem Cell Mobilization Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Stem Cell Mobilization Epidemiology https://www.delveinsight.com/report-store/stem-cell-mobilization-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Stem Cell Mobilization Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
• Psoriasis Market: https://www.delveinsight.com/report-store/psoriasis-market
• Tendinitis Market: https://www.delveinsight.com/report-store/tendonitis-market
• Vascular Closure Devices Market: https://www.delveinsight.com/report-store/vascular-closure-devices-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Hydrocephalus Market: https://www.delveinsight.com/report-store/hydrocephalus-market
• Hemophilia A Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Herpes Simplex Virus Market: https://www.delveinsight.com/report-store/genital-herpes-market
• Peripheral Nerve Injuries Market: https://www.delveinsight.com/infographics/peripheral-nerve-injuries-market
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stem Cell Mobilization Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Teva Pharmaceuticals, Gilead Sciences here
News-ID: 4062426 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Stem
Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of…
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume.
My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and…
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).
Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941
Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that…
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022
The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive…
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…
